Curiox Biosystems And Beckman Coulter Life Sciences Announces Partnership Combining C-FREE Technology With DURA Innovations For Hands-Free Washed Sample Preparation For Flow Cytometry
Portfolio Pulse from Benzinga Newsdesk
Curiox Biosystems and Beckman Coulter Life Sciences have announced a partnership to integrate Curiox's C-FREE technology with Beckman Coulter's DURA Innovations. This collaboration aims to enhance flow cytometry by offering hands-free washed sample preparation, potentially improving efficiency and accuracy in laboratories.
May 03, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Danaher Corporation, the parent company of Beckman Coulter Life Sciences, could see a positive impact from this partnership due to the potential market growth and innovation in flow cytometry.
The partnership between Curiox Biosystems and Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation (DHR), to integrate innovative technologies for flow cytometry could lead to enhanced product offerings and market competitiveness for DHR. This collaboration is likely to be viewed positively by investors, as it demonstrates DHR's commitment to innovation and could potentially increase its market share in the flow cytometry sector.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80